BRCA1 Immunohistochemical Staining as a Prognostic Indicator in Uterine Serous Carcinoma

James P Beirne, Jennifer Quinn, Perry Maxwell, Steve E Kalloger, Jessica McAlpine, C Blake Gilks, Ian J G Harley, W Glenn McCluggage

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


OBJECTIVES: The objective of this study was to investigate the relationship between BRCA1 protein expression, as determined by immunohistochemistry, and clinical outcome in uterine serous carcinoma (USC). METHODS: A tissue microarray containing duplicate cores of 73 cases of USC was immunohistochemically stained with mouse anti-BRCA1 (Ab-1) mouse monoclonal (MS110) antibody. The cores were scored in a semiquantitative manner evaluating both the distribution and intensity of nuclear staining. BRCA1 protein expression was correlated with progression-free survival. RESULTS: Seventy-two of 73 cases were assessable, and there was a statistically significant decreased progression-free survival for those cases exhibiting tumor cell nuclei staining of 76% or greater (P = 0.0023). CONCLUSIONS: Our study illustrates that a low level of BRCA1 protein expression is a favorable prognostic indicator in USC, similar to what is observed in high-grade serous ovarian carcinoma. Further studies should focus on the BRCA1 status of USCs at a molecular level and also investigate whether BRCA1 protein expression is associated with response to chemotherapy in USC.

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology


Dive into the research topics of 'BRCA1 Immunohistochemical Staining as a Prognostic Indicator in Uterine Serous Carcinoma'. Together they form a unique fingerprint.

Cite this